6505--Cyclobenzaprine Tablets (VA-25-00015093)
ID: 36E79725R0009Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/0dbeeba423ee4f8c8a069ea4114097ba/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified contractors to supply Cyclobenzaprine HCL Tablets under solicitation number VA-25-00015093. The procurement involves providing pharmaceutical supplies over a base year and four option years, with specific requirements for submission formats, safety protocols, and compliance with drug supply chain security standards. Cyclobenzaprine is a critical medication used for muscle relaxation, making this procurement essential for ensuring consistent availability for veterans and healthcare facilities. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details regarding the submission process and compliance requirements.

    Point(s) of Contact
    Kenneth LayContract Specialist
    Kenneth.Lay@va.gov
    Files
    Title
    Posted
    36E79725R0009_1.docx
    The document is a solicitation for pharmaceutical supplies, specifically Cyclobenzaprine HCL Tablets, issued by the Department of Veterans Affairs. It outlines the requirements and terms for potential contractors to provide these drugs under a federal procurement framework. Key components include the invitation to offer prices for various bottle sizes over a base year and four option years, with strict guidelines on submission formats and requirements for safety protocols, including unique National Drug Codes (NDCs) for products. The solicitation stipulates that bids must include a Cost Recovery Fee and adhere to compliance standards related to drug supply chain security. The document emphasizes the importance of maintaining good manufacturing practices and the necessity for the selected contractor to establish business-to-business agreements with pharmaceutical prime vendors for efficient distribution. Additionally, there are provisions for reporting sales, handling drug recalls, and ensuring ongoing compliance with federal regulations. This solicitation reflects the VA's structured approach to sourcing essential pharmaceuticals, aiming to ensure consistency and availability for veterans and affiliated healthcare facilities through regulated vendor engagements.
    36E79725R0009.docx
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a consistent supply of these pharmaceuticals for not only the VA but also for the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four optional one-year extensions. Vendors must provide specific drug labeling and a unique National Drug Code (NDC). The RFP will be released electronically around December 20, 2024, with a submission deadline of January 3, 2025. Interested suppliers can obtain further information and amendments via sam.gov. The document outlines estimated annual usage for various package sizes of Cyclobenzaprine HCL Tablets, indicating substantial demand across different formats. This procurement reflects the government's commitment to ensuring that veterans and associated health care systems have access to essential medications.
    Lifecycle
    Title
    Type
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Currently viewing
    Solicitation
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Presolicitation
    Similar Opportunities
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Baclofen Tablets under the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while complying with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is crucial for maintaining the pharmaceutical needs of VA facilities, addressing issues such as compliance, backorders, and recalls. Interested offerors must submit their proposals by February 5, 2025, at 2:30 PM CST, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.
    6505--Diclofenac Sodium (NA) 1% Gel
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Diclofenac Sodium (NA) 1% Gel, a pharmaceutical product essential for pain management in patients. This presolicitation opportunity falls under the Pharmaceutical Preparation Manufacturing industry, specifically categorized under the NAICS code 325412 and PSC code 6505, indicating its relevance in the drugs and biologicals sector. The procurement aims to ensure the availability of this critical medication for veterans, highlighting its importance in providing effective treatment options. Interested vendors can reach out to Contract Specialist Ray Roldan at raymond.roldan@va.gov or call 708-786-4930 for further details regarding the solicitation process.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0117 770-25-2-0182 - National CMOP T0224 TERBINAFINE HCL 1% CREAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Terbinafine HCL 1% Cream for its Consolidated Mail Outpatient Pharmacy (CMOP) facilities across multiple locations. This acquisition, identified by solicitation number 36C77025Q0117, is set aside for small businesses and requires vendors to provide specific documentation, including a completed price schedule in Excel format and a state wholesale distributor license, to ensure compliance with the Drug Supply Chain Security Act. The timely delivery of these pharmaceuticals is crucial for maintaining a reliable supply for veterans, with a delivery timeframe of 10 days after receipt of order and shipments directed to seven designated CMOP locations. Interested vendors must submit their quotes by January 23, 2025, with an estimated award date of January 28, 2025; for further inquiries, contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--Domestic Pharmaceuticals/Med/Surge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.
    6505--Nadolol Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Nadolol tablets as part of its Pharmaceutical Prime Vendor Program. This solicitation requires bidders to provide various dosages of Nadolol, along with unique National Drug Codes (NDCs), and to adhere to strict compliance with federal manufacturing practices and regulations, including the Drug Supply Chain Security Act. The consistent supply of these pharmaceuticals is crucial for meeting the healthcare needs of veterans, ensuring they receive necessary medications without interruption. Interested parties should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must adhere to the submission requirements outlined in the solicitation document, which includes a 0.5% cost recovery fee and specific timelines for bid submission.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Bicalutamide 50MG tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is issuing a solicitation for a national requirements contract for Bicalutamide 50MG tablets, available in bottle counts of 30 and 500. The procurement aims to establish a reliable supply source for these pharmaceutical items, which are critical for various Department of Defense and other federal health programs, including the Department of Veterans Affairs and the Indian Health Service. This unrestricted and fully competitive acquisition will be a firm-fixed price contract with a one-year base and four one-year options, with proposals due by January 24, 2025. Interested parties can reach out to Keith Ryales at keith.ryales@dla.mil or 215-737-9199 for further inquiries and are encouraged to monitor the DLA Bid Board System and SAM.gov for updates on the solicitation.
    6505--Metformin SA Tablets REPACK PROGRAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Metformin SA Tablets through a repack program, as outlined in solicitation 36E79725R0003. Bidders are required to meet specific packaging standards, including the use of safety-caps that can be converted or deshelled, with bottles having a minimum size of 120cc and a cylindrical design that accommodates a label of specified dimensions. This procurement is critical for ensuring the availability of essential pharmaceutical products for veteran populations, adhering to FDA regulations and maintaining healthcare quality. Interested parties must submit their offers by January 28, 2025, at 2:30 PM CST, and can direct inquiries to Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.